Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Zintellect
- Harvard University
- Center for Drug Evaluation and Research (CDER)
- University of Michigan
- Center for Devices and Radiological Health (CDRH)
- University of Texas at Austin
- City of Hope
- Center for Biologics Evaluation and Research (CBER)
- Cornell University
- National Center for Toxicological Research (NCTR)
- Missouri University of Science and Technology
- University of Maryland, Baltimore
- Princeton University
- Central Michigan University
- Indiana University
- Pennsylvania State University
- The University of Alabama
- Carnegie Mellon University
- James Madison University
- National Institute of Allergy and Infectious Diseases, NIH
- Oden Institute for Computational Engineering and Sciences
- Office of the Commissioner (OC)
- University of Florida
- University of Miami
- University of Washington
- Villanova University
- Brandeis University
- Cellular and Molecular Therapeutics Branch, NHLBI, NIH
- Claremont McKenna College
- Dana-Farber Cancer Institute (DFCI)
- Duke University
- Indiana State University
- Johns Hopkins Medicine - Laboratory of Human Biomimetics
- Margaret M Redfield
- New York University Grossman School of Medicine (Torres-Vázquez lab)
- Office of Women's Health Grant Program (OWH GP)
- Open Society Foundations
- SUNY
- Saint Louis University
- Stephen & Denise Adams Center for Parkinson's Disease at Yale School of Medicine
- The Ohio State University
- The University of Iowa
- The University of Texas MD Anderson Cancer Center
- University of California
- University of Denver
- University of Kansas Medical Center
- University of Kentucky
- University of Minnesota
- University of North Carolina at Charlotte
- Weill Cornell Medicine - Chandwani Laboratory
- Yale University
- eQuest
- 42 more »
- « less
-
Field
-
practitioners to pursue curiosity-driven research, expand human understanding, and grapple with questions that demand insight from across disciplines. The Fellowship Program annually supports the work of 50
-
sensitivities of various subtypes of SCLC. We utilize and develop both murine and human models of lung cancer to test our strategies. Our long-term goal is to develop novel therapeutic strategies
-
experiments using cell culture, organoids, animal models, and human tissues o Conduct bioinformatics analyses of high-throughput sequencing data o Interpret and present findings through scientific
-
need assistance searching or applying for jobs please contact us at (540) 568-3597 or [email protected]. You may also visit the JMU Human Resource Office, located at 752 Ott Street, Harrisonburg, VA 22807 and
-
of thriving from work and its relationship with key organizational enterprise outcomes (such as turnover and productivity). Research will also be focused on the future of work, such as the implementation of AI
-
-Derm (6) Institute for Human Dev (6) Life Sciences Center (6) Mechanical & Aerospace Engin (6) Medicine-General Internal (6) Medicine-Pulmonary & Environ (6) Professional Coding & Revenue (6) Advancement
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 6 hours ago
(SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest
-
the full fellowship lifecycle: including application, selection, and onboarding, collaborating closely with Human Resources, the Office of Research Administration, and the Salesforce team to support all
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 6 hours ago
immunogenicity data from FDA internal databases Develop a population model with these data using a nonlinear mixed effect modeling approach and perform sensitivity analysis Evaluate the relationship between
-
Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 6 hours ago
include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an